ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,797Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 16

$1.14M Total Retail Price of All Prescriptions

Rank: 1 out of 16

462 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 2,881 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$197 was the average price of a prescription from this provider, compared to $204 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
PEN NEEDLE 426 207 1 2
LANTUS SOLOSTAR 367 192 2 7
LANTUS 309 160 3 3
GLIPIZIDE 251 119 4 12
LEVOTHYROXINE SODIUM 238 123 5 1
METFORMIN HCL 211 57 6 11
INSULIN SYRINGE 205 98 7 8
BYETTA 190 65 8 16
NOVOLOG FLEXPEN 174 80 9 15
HUMALOG 172 89 10 5
ATORVASTATIN CALCIUM 155 76 11 18
PRAVASTATIN SODIUM 151 52 12 21
LISINOPRIL 150 52 13 22
HUMALOG MIX 75-25 131 59 14 25
METFORMIN HCL ER 130 56 15 13
LOSARTAN POTASSIUM 127 60 16 26
JANUVIA 124 68 17 10
GLIPIZIDE XL 107 71 18 29
GLIPIZIDE ER 89 74 19 23
HUMULIN R 80 27 20 30
NOVOLOG 79 21 21 14
CRESTOR 72 32 22 24
GABAPENTIN 69 33 23 31
AMLODIPINE BESYLATE 65 38 24 32
LIPITOR 62 38 25 35
METHIMAZOLE 61 55 26 9
NOVOLOG MIX 70-30 FLEXPEN 61 34 26 36
SIMVASTATIN 60 31 28 20
VICTOZA 3-PAK 58 26 29 17
LEVEMIR FLEXPEN 56 20 30 28
ZETIA 55 16 31 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.